| Peficitinib |
培菲替尼 |
944118-01-8 |
| 4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide |
BLZ945 |
953769-46-5 |
| 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(triMethylsilyl)ethoxy]Methyl]-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-, (βS)- |
鲁索利尼杂质C |
941685-41-2 |
| 4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE |
4-氯-7-[[2-(三甲基硅烷基)乙氧基]甲基]-7H-吡咯并[2,3-D]嘧啶 |
941685-26-3 |
| 3-Cyano-5-(trifluoroMethyl)benzoic Acid |
3-氰基-5-三氟甲基苯甲酸 |
942077-16-9 |
| 1-tert-butyl 3-Methyl 3-aMinopyrrolidine-1,3-dicarboxylate |
1-tert-butyl 3-Methyl 3-aMinopyrrolidine-1,3-dicarboxylate |
942190-47-8 |
| LCZ696 |
LCZ696 |
936623-90-4 |
| 4-(3-(allyloxymethyl)phenyl)-2-chloropyrimidine |
937273-29-5 |
937273-29-5 |
| PACRITINIB |
帕克替尼 |
937272-79-2 |
| Ponatinib |
帕纳替尼 |
943319-70-8 |
| N-(2,6-dichloro-3,5-dimethoxyphenyl)acetamide |
943189-21-7 |
943189-21-7 |
| N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide |
CS-2774 |
942206-85-1 |
| BIBF-1120 |
BIBF-1120 |
928326-83-4 |
| 929121-23-3 |
929121-23-3 |
929121-23-3 |
| PBMC |
PBMC |
925978-92-3 |
| 6-chloro-5-iodopyrazin-2-amine |
6-氯-5-碘吡嗪-2-氨 |
925678-00-8 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-26-8 |
| ethyl 4-methyl-3-((4-(pyrazin-2-yl)pyrimidin-2-yl)amino)benzoate |
926038-04-2 |
926038-04-2 |
| SAR245409 |
VOXTALISIB |
934493-76-2 |
| 2-Thiophenecarboxylic acid, 5-aMino-3-[(1R)-1-[2-(trifluoroMethyl)phenyl]ethoxy]-, Methyl ester |
GSK-461364A中间体 |
929039-92-9 |
